ODESSA, Texas (KMID/KPEJ) – Dr. Manohar Angirekula, Dr. Adam Farber, and Dr. Fernando Boccalandro have successfully implanted the first “Watchman FLX” Pro Device at Medical Center Hospital.

The Lovelace Heart Hospital is celebrating the new addition of their 1,000th heart device. Called the Watchman, the device ...

The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent ...

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Larry ...

Boston Scientific announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX device.

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

5.0%). The OPTION trial included 1,600 patients. In the trial, approximately 60% of device patients had their WATCHMAN FLX ...

(Courtesy photo) The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally ...

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their ...

Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...

In the trial, approximately 60% of device patients had their WATCHMAN FLX implant 90-180 days following their ablation procedure. The other nearly 40% of the device patients had the two procedures ...